Concepedia
1
Publications
10
Citations
H-Index
2022
Active since
Affiliations
Resolve Therapeutics (United States)(Current)
Anjana Agarwal is an author at Resolve Therapeutics (United States).
Publications per year
2022–2022
Abstract 3263: Preclinical characterization of PRT3789, a potent and selective SMARCA2 targeted degrader
Michael Hulse, Anjana Agarwal, Min Wang et al. · Cancer Research · 2022 · 10 citations
Rows per page
1–1 of 1